Company Fact Sheet

Contact Us | Sitemap

About ISTA

Company Fact Sheet

Company Presentations

Executive Management

Board of Directors

Press Releases

ISTA's Board Reiterates Commitment to Maximizing Shareholder Value Through Strategic Review Process
ISTA Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Study of BEPOSONE(TM) (Bepotastine Besilate - Steroid Combination Nasal Spray) for the Treatment of Symptoms Associated With Seasonal Allergic Rhinitis
ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan

Company Fact Sheet